These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 34034718

  • 1. Bone Sclerostin and Dickkopf-related protein-1 are positively correlated with bone mineral density, bone microarchitecture, and bone strength in postmenopausal osteoporosis.
    Peng J, Dong Z, Hui Z, Aifei W, Lianfu D, Youjia X.
    BMC Musculoskelet Disord; 2021 May 25; 22(1):480. PubMed ID: 34034718
    [Abstract] [Full Text] [Related]

  • 2. Relationships between sclerostin and morphometric vertebral fractures, bone mineral density, and bone microarchitecture in postmenopausal women.
    Liang H, Qi W, Yu F, Jiajue R, Chi Y, Liu W, Wang O, Li M, Xing X, Yu W, Jiang Y, Xia W.
    Arch Osteoporos; 2023 Apr 29; 18(1):57. PubMed ID: 37120433
    [Abstract] [Full Text] [Related]

  • 3. Effect of glucocorticoid treatment on Wnt signalling antagonists (sclerostin and Dkk-1) and their relationship with bone turnover.
    Gifre L, Ruiz-Gaspà S, Monegal A, Nomdedeu B, Filella X, Guañabens N, Peris P.
    Bone; 2013 Nov 29; 57(1):272-6. PubMed ID: 23981659
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Association of serum osteocalcin with bone microarchitecture and muscle mass in Beijing community-dwelling postmenopausal women.
    Liu S, Pang Q, Guan W, Yu F, Wang O, Li M, Xing X, Yu W, Jiang Y, Xia W.
    Endocrine; 2024 Apr 29; 84(1):236-244. PubMed ID: 38206435
    [Abstract] [Full Text] [Related]

  • 8. Association of serum sclerostin with bone mineral density, bone turnover, steroid and parathyroid hormones, and fracture risk in postmenopausal women: the OFELY study.
    Garnero P, Sornay-Rendu E, Munoz F, Borel O, Chapurlat RD.
    Osteoporos Int; 2013 Feb 29; 24(2):489-94. PubMed ID: 22525978
    [Abstract] [Full Text] [Related]

  • 9. The roles of sclerostin and irisin on bone and muscle of orchiectomized rats.
    Zhou BN, Zhang Q, Lin XY, Hu J, Zhao DC, Jiang Y, Xing XP, Li M.
    BMC Musculoskelet Disord; 2022 Dec 02; 23(1):1049. PubMed ID: 36456918
    [Abstract] [Full Text] [Related]

  • 10. Effect of Teriparatide Treatment on Circulating Periostin and Its Relationship to Regulators of Bone Formation and BMD in Postmenopausal Women With Osteoporosis.
    Gossiel F, Scott JR, Paggiosi MA, Naylor KE, McCloskey EV, Peel NFA, Walsh JS, Eastell R.
    J Clin Endocrinol Metab; 2018 Apr 01; 103(4):1302-1309. PubMed ID: 29365099
    [Abstract] [Full Text] [Related]

  • 11. Serum sclerostin levels associated with lumbar spine bone mineral density and bone turnover markers in patients with postmenopausal osteoporosis.
    Xu XJ, Shen L, Yang YP, Lu FR, Zhu R, Shuai B, Li CG, Wu MX.
    Chin Med J (Engl); 2013 Jul 01; 126(13):2480-4. PubMed ID: 23823821
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Wnt signaling pathway inhibitors, sclerostin and DKK-1, correlate with pain and bone pathology in patients with Gaucher disease.
    Ivanova MM, Dao J, Kasaci N, Friedman A, Noll L, Goker-Alpan O.
    Front Endocrinol (Lausanne); 2022 Jul 01; 13():1029130. PubMed ID: 36506070
    [Abstract] [Full Text] [Related]

  • 14. Ibandronate increases sclerostin levels and bone strength in male patients with idiopathic osteoporosis.
    Muschitz C, Kocijan R, Pahr D, Patsch JM, Amrein K, Misof BM, Kaider A, Resch H, Pietschmann P.
    Calcif Tissue Int; 2015 Jun 01; 96(6):477-89. PubMed ID: 25911186
    [Abstract] [Full Text] [Related]

  • 15. Serum sclerostin levels were positively correlated with fat mass and bone mineral density in central south Chinese postmenopausal women.
    Sheng Z, Tong D, Ou Y, Zhang H, Zhang Z, Li S, Zhou J, Zhang J, Liao E.
    Clin Endocrinol (Oxf); 2012 Jun 01; 76(6):797-801. PubMed ID: 22151063
    [Abstract] [Full Text] [Related]

  • 16. High circulating sclerostin is present in patients with thalassemia-associated osteoporosis and correlates with bone mineral density.
    Voskaridou E, Christoulas D, Plata E, Bratengeier C, Anastasilakis AD, Komninaka V, Kaliontzi D, Gkotzamanidou M, Polyzos SA, Dimopoulou M, Terpos E.
    Horm Metab Res; 2012 Nov 01; 44(12):909-13. PubMed ID: 22581647
    [Abstract] [Full Text] [Related]

  • 17. TBS reflects trabecular microarchitecture in premenopausal women and men with idiopathic osteoporosis and low-traumatic fractures.
    Muschitz C, Kocijan R, Haschka J, Pahr D, Kaider A, Pietschmann P, Hans D, Muschitz GK, Fahrleitner-Pammer A, Resch H.
    Bone; 2015 Oct 01; 79():259-66. PubMed ID: 26092650
    [Abstract] [Full Text] [Related]

  • 18. Effect of aromatase inhibition on serum levels of sclerostin and dickkopf-1, bone turnover markers and bone mineral density in women with breast cancer.
    Kyvernitakis I, Rachner TD, Urbschat A, Hars O, Hofbauer LC, Hadji P.
    J Cancer Res Clin Oncol; 2014 Oct 01; 140(10):1671-80. PubMed ID: 24903965
    [Abstract] [Full Text] [Related]

  • 19. Role of sclerostin in the bone loss of postmenopausal chinese women with type 2 diabetes.
    Zhou YJ, Li A, Song YL, Zhou H, Li Y, Tang YS.
    Chin Med Sci J; 2013 Sep 01; 28(3):135-9. PubMed ID: 24074614
    [Abstract] [Full Text] [Related]

  • 20. Correlates of bone microarchitectural parameters and serum sclerostin levels in men: the STRAMBO study.
    Szulc P, Boutroy S, Vilayphiou N, Schoppet M, Rauner M, Chapurlat R, Hamann C, Hofbauer LC.
    J Bone Miner Res; 2013 Aug 01; 28(8):1760-70. PubMed ID: 23408601
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.